| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $616K | +69.9% |
| SG&A Expense | $1.8M | +61.6% |
| Operating Income | -$2.8M | -56.9% |
| Income Tax | $0 | — |
| Net Income | -$2.8M | -57.3% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.4M | -31.6% |
| Total Assets | $1.5M | -31.5% |
| Current Liabilities | $10K | +22.7% |
| Stockholders' Equity | -$2.0M | -49.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | -26.7% |
| Financing Cash Flow | $1.3M | — |